These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Assessment of prolactin release in pituitary dwarfism with the sulpiride test. Batrinos ML; Pavlou SN; Pitoulis SA; Sfikaki AP; Anousakis C; Alexandrides TK; Piaditis GP Clin Endocrinol (Oxf); 1978 Mar; 8(3):197-205. PubMed ID: 639331 [TBL] [Abstract][Full Text] [Related]
46. Hyperprolactinaemia in male diabetics. Mooradian AD; Morley JE; Billington CJ; Slag MF; Elson MK; Shafer RB Postgrad Med J; 1985 Jan; 61(711):11-4. PubMed ID: 3991396 [TBL] [Abstract][Full Text] [Related]
47. The sulpiride test in panhypopituitarism. Batrinos ML; Pavlou SN; Pitoulis SA; Sfikaki AP; Alexandrides TK; Piaditis GP Clin Endocrinol (Oxf); 1978 Mar; 8(3):193-6. PubMed ID: 639330 [TBL] [Abstract][Full Text] [Related]
48. [Hyperprolactinemia induced with sulpiride in patients with essential arterial hypertension]. Frisina N; De Luca A; Costa G; Buemi M; Macrì I; Nicita-Mauro V Boll Soc Ital Cardiol; 1978; 23(2):362-7. PubMed ID: 754793 [No Abstract] [Full Text] [Related]
49. Sulpiride-induced hyperprolactinemia and impotence in male psychiatric outpatients. Weizman A; Maoz B; Treves I; Asher I; Ben-David M Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):193-8. PubMed ID: 4001434 [TBL] [Abstract][Full Text] [Related]
50. An investigation of the association between the level of prolactin in serum and type II diabetes. Manshaei N; Shakibaei F; Fazilati M; Salavati H; Negahdary M; Palizban A Diabetes Metab Syndr; 2019; 13(5):3035-3041. PubMed ID: 30030156 [TBL] [Abstract][Full Text] [Related]
51. Prolactin releasing effect of sulpiride isomers in rats and man. Müller EE; Stefanini E; Camanni F; Locatelli V; Massara F; Spano PF; Cocchi D J Neural Transm; 1979; 46(3):205-14. PubMed ID: 528995 [No Abstract] [Full Text] [Related]
52. Conjugation of sulpiride with a cell penetrating peptide to augment the antidepressant efficacy and reduce serum prolactin levels. Liang Y; Yang Y; Huang R; Ning J; Bao X; Yan Z; Chen H; Ding L; Shu C Biomed Pharmacother; 2024 May; 174():116610. PubMed ID: 38642503 [TBL] [Abstract][Full Text] [Related]
53. Compositional changes in lipoproteins of subjects with non-insulin-dependent diabetes mellitus. Haffner SM J Lab Clin Med; 1991 Aug; 118(2):109-10. PubMed ID: 1856574 [No Abstract] [Full Text] [Related]
54. [Indicators of carbohydrate metabolism and its regulation in patients with hyperprolactinemia]. Mel'nichenko GA; Gitel' EP; Vorob'ev DV; Dreval' AV Akush Ginekol (Mosk); 1987 May; (5):38-9. PubMed ID: 3303989 [No Abstract] [Full Text] [Related]
55. [Prolactin in breast cancer]. Hernández Antequera E; Dapena Crespo MA; Gutiérrez Moro MC; Vinagre Velasco LM; Requena Guerrero F; Gómez de Tejada R; García-Sancho L Rev Esp Oncol; 1981; 28(2):161-7. PubMed ID: 7052965 [No Abstract] [Full Text] [Related]
56. [Medium-level glucose control in non-insulin-dependent diabetics in Dakar]. Sidibe EH Presse Med; 1996 Sep; 25(25):1167. PubMed ID: 8949614 [No Abstract] [Full Text] [Related]
57. Exaggerated prolactin response to metoclopramide in non-insulin dependent diabetes mellitus. Krassowski J; Jeske W Horm Metab Res; 1982 Mar; 14(3):165. PubMed ID: 7068109 [No Abstract] [Full Text] [Related]
58. [Nicardipine may have an adverse effect on the blood sugar equilibrium of non-insulin-dependent diabetics]. Belleville I; Vaillant G; Farnier M; Brun JM Presse Med; 1987 Oct; 16(35):1760-1. PubMed ID: 2962094 [No Abstract] [Full Text] [Related]
59. Severe diabetic microangiopathy with normal glucose tolerance and pituitary infarction. Bilous RW; Poston RN; Keen H; Viberti GC Br Med J (Clin Res Ed); 1983 Oct; 287(6400):1168-9. PubMed ID: 6414614 [TBL] [Abstract][Full Text] [Related]
60. Possible role of insulin deficiency and growth hormone in severe retinopathy. Jennings PE; Odugbesan O; Fetcher J; Barnett AH Lancet; 1985 Aug; 2(8453):501. PubMed ID: 2863521 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]